Physician profile
Eric C Parlette
NPI 1386624567
$1,299.15
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2022: $446 · 2023: $451 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.93 | 2022-2024 | |
| Genentech USA, INC. | $119.55 | 2019 | |
| Ucb, INC. | $109.63 | 2022-2024 | Briviact |
| Incyte Corporation | $95.68 | 2022-2024 | Opzelura |
| Amgen INC. | $84.07 | 2022-2024 | Otezla, Enbrel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $77.34 | 2019 | |
| Sun Pharmaceutical Industries INC. | $75.64 | 2022-2024 | Winlevi |
| Leo Pharma INC. | $71.70 | 2022-2023 | Adbry |
| Lilly USA, LLC | $53.70 | 2022-2023 | Taltz, Olumiant |
| Dermavant Sciences, INC. | $43.71 | 2023-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $40.62 | 2022-2023 | Sotyktu |
| Janssen Biotech, INC. | $31.45 | 2022-2023 | Tremfya |
| Integra Lifesciences Corporation | $29.24 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocon Biologics INC | $26.27 | 2023 | Hulio |
| Genzyme Corporation | $23.77 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $23.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.80 | 2024 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Parlette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.